916.7000 10.35 (1.14%)
NSE Oct 07, 2025 15:49 PM
Volume: 97,141
 

916.70
1.14%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues grew 8% YoY to | 840 crore (I-direct estimate: | 755 crore) mainly on account of 14% YoY increase in domestic business to | 349 crore (I-direct estimate: | 364 crore). Export sales grew 3% YoY to | 311 crore (I-direct estimate: | 258 crore), led by 4% YoY growth in the US business to ~| 235 crore (I-direct estimate: ~| 192 crore) EBITDA margins improved 361 bps YoY to 22.3% (I-direct estimate: 21.8%) led by lower R&D; expenditure. EBITDA increased 29% YoY to...
Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended